Evidence map›Paper›PMID 11181702›Full record

ArticleThe Journal of experimental medicine2001

Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein rR and Bcl-2.

E Jacotot, K F Ferri, C El Hamel, C Brenner, S Druillennec, J Hoebeke, P Rustin, D Métivier, C Lenoir, M Geuskens and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 267 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Animal Coronaviruses Induced Apoptosis.Life (Basel, Switzerland) · 2021
    Review
  13. Mitocanic Di- and Triterpenoid Rhodamine B Conjugates.Molecules (Basel, Switzerland) · 2020
    Review
  14. Review
  15. Genetic variation and function of the HIV-1 Tat protein.Medical microbiology and immunology · 2019
    Review
  16. Article
  17. Article
  18. Adipose Tissue in HIV Infection.Comprehensive Physiology · 2017
    Review
  19. Article
  20. The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.International journal of molecular sciences · 2017
    Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

E JacototCentre National de la Recherche Scientifique, UMR 1599, Institut Gustave Roussy, F-94805 Villejuif, France.
K F Ferri
C El Hamel
C Brenner
S Druillennec
J Hoebeke
P Rustin
D Métivier
C Lenoir
M Geuskens
H L Vieira
M Loeffler
A S Belzacq
J P Briand
N Zamzami
L Edelman
Z H Xie
J C Reed
B P Roques
G Kroemer
Institut Gustave Roussy · FRUniversité Paris Cité · FRInstitut de Biologie Moléculaire et Cellulaire · FRSanford Burnham Prebys Medical Discovery Institute · USInserm · FRInstitut Pasteur · FRUniversité de Technologie de Compiègne · FR

Funding

Mitochondria and Apoptosis (revised GM60554)R01GM060554 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI REED, JOHN C · 2000 to 2009
$3.5M
NIGMS NIH HHS R01 GM060554
6 · The paper itself

Abstract

Viral protein R (Vpr), an apoptogenic accessory protein encoded by HIV-1, induces mitochondrial membrane permeabilization (MMP) via a specific interaction with the permeability transition pore complex, which comprises the voltage-dependent anion channel (VDAC) in the outer membrane (OM) and the adenine nucleotide translocator (ANT) in the inner membrane. Here, we demonstrate that a synthetic Vpr-derived peptide (Vpr52-96) specifically binds to the intermembrane face of the ANT with an affinity in the nanomolar range. Taking advantage of this specific interaction, we determined the role of ANT in the control of MMP. In planar lipid bilayers, Vpr52-96 and purified ANT cooperatively form large conductance channels. This cooperative channel formation relies on a direct protein-protein interaction since it is abolished by the addition of a peptide corresponding to the Vpr binding site of ANT. When added to isolated mitochondria, Vpr52-96 uncouples the respiratory chain and induces a rapid inner MMP to protons and NADH. This inner MMP precedes outer MMP to cytochrome c. Vpr52-96-induced matrix swelling and inner MMP both are prevented by preincubation of purified mitochondria with recombinant Bcl-2 protein. In contrast to König's polyanion (PA10), a specific inhibitor of the VDAC, Bcl-2 fails to prevent Vpr52-96 from crossing the mitochondrial OM. Rather, Bcl-2 reduces the ANT-Vpr interaction, as determined by affinity purification and plasmon resonance studies. Concomitantly, Bcl-2 suppresses channel formation by the ANT-Vpr complex in synthetic membranes. In conclusion, both Vpr and Bcl-2 modulate MMP through a direct interaction with ANT.

Indexed as

Amino Acid SequenceGene Products, vprHIV-1Intracellular MembranesIon ChannelsLiposomesMitochondriaMitochondrial ADP, ATP TranslocasesModels, BiologicalModels, MolecularMolecular Sequence DataOxygen ConsumptionPeptide FragmentsPermeabilityProtein BindingProto-Oncogene Proteins c-bcl-2Gene Products, vprIon ChannelsLiposomesMitochondrial ADP, ATP TranslocasesPeptide FragmentsProto-Oncogene Proteins c-bcl-2vpr Gene Products, Human Immunodeficiency Virus

Identifiers

PMID11181702
PMCPMC2195906
OpenAlexW2171268838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.